Indications for neuromuscular blockade in tracheal intubation. Planned surgery and patients with no particular risk during the pre-anaesthesia exam;Indications de la curarisation pour l'intubation tracheale. Chirurgie programmee, patients sans risque particulier lors de l'examen

Annales Francaises d'Anesthesie et de Reanimation

Volumn 19, Issue SUPPL. 2, 2000, Pages 378-386

  Beaussier, M ^a   Raucoules Aime, M ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CISATRACURIUM; MIVACURIUM; RAPACURONIUM BROMIDE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

CONFERENCE PAPER; ENDOTRACHEAL INTUBATION; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; NEUROMUSCULAR BLOCKING; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING;

HUMANS; INTUBATION, INTRATRACHEAL; MEDLINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 0033809889     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (85)

1. La pratique de l'anesthesie en France en 1996. Organisation et technique de l'anesthesie
2. La pratique de l'anesthesie en France en 1996. Anesthesies en chirurgie
3. Comparative use of muscle relaxants and their reversal in three European countries: A survey in France, Germany and Great Britain
4. Observations on the action of thiopental on the laryngeal reflex
5. The effect of thiopentone and propofol on upper airway integrity
6. Preliminary observations of vocal cords movements on induction of anaesthesia with propofol or thiopentone
7. End-tidal halothane concentration for endotracheal intubation
8. Determination of end-tidal sevoflurane concentration for tracheal intubation and minimal alveolar anesthetic concentation in adults
9. Tracheal intubation using alfentanil and no muscle relaxant: Is the choise of hypnotic important?
10. Injection pain, intubating conditions and cardiovascular changes following induction of anaesthesia with propofol alone or in combination with alfentanil
11. Propofol as the main anaesthetic agent in dental surgery
12. Tracheal intubation without the use of muscle relaxants: A technique using propofol and varying doses of alfentanil
13. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and IV lidocaine
14. Comparison of intubation following propofol and alfentanil with intubation following thiopentone and suxamethonium
15. Tracheal intubation in ambulatory surgery patients: Using remifentanil and propofol without muscle relaxants
16. Hemodynamic response to induction and intubation. Propofol/ fentanyl interaction
17. Intravenous lidocaine as a suppressant of coughing during tracheal intubation
18. The effect of topical lignocaine on intubating conditions after propofol-alfentanil induction
19. Induction of anesthesia and tracheal intubation with sevoflurane in adults
20. Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426): A comparison with suxamethonium
21. Intubating conditions provided by propofol and alfentanil-acceptable, but not ideal
22. A comparison of the intubation conditions between mivacurium and rocuronium during balanced anesthesia
23. Monitoring the onset of neuromuscular block at the orbicularis oculi can predict good intubating conditions during atracurium-induced neuromuscular block
24. Influence of anaesthesia and muscle relaxation on intubating conditions and sympathoadrenal response to tracheal intubation
25. Ventilatory compliance after three sufentanil-pancuronium induction sequences
26. Physiology of alfentanil-induced rigidity
27. Comparison of intubating conditions after administration of Org 9426 (rocuronium) and suxamethonium
28. Pharmacologie des myorelaxants et leurs antagonistes
29. Faut-il encore utiliser la succinylcholine ?
30. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug
31. Comparison of rocuronium and mivacurium during outpatient laparoscopic surgery
32. Mivacurium as an alternative to succinylcholine during outpatient laparoscopy
33. Use of mivacurium during laparoscopic surgery : Effect of reversal drugs on postoperative recovery
34. The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia
35. Efficacy and safety of divided dose administration of mivacurium for a 90-seconds tracheal intubation
36. Time course of action and endotracheal intubation conditions of ORG 9427, a new short acting steroidal muscle relaxant ; a comparison with succinylcholine
37. Dose-ranging study in younger adult and elderly patients of ORG 9487, a new, rapid onset, short duration muscle relaxant
38. Atracurium and vecuronium : Effect of dose on time of onset
39. Comparison of atracurium, and vecuronium for tracheal intubation
40. Intubating conditions with ORG NC45
41. The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study
42. Neuromuscular and cardiovascular effects of high-dose vecuronium
43. Intubation conditions after atracurium and suxamethonium
44. Hemodynamic effects of atracurium, vecuronium and pancuronium during sufentanil anaesthesia for coronary artery bypass
45. Comparison of atracurium and vecuronium during anaesthesia for laparoscopy
46. A comparison of cisatracurium and atracurium : Onset of neuromuscular block after bolus injection and rapid recovery after subsequent infusion
47. Intubating conditions following 1R cis 1'R cis atracurium (51W89). A comparison with atracurium
48. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration
49. Rocuronium bromide in dental day case anaesthesia - A comparison with atracurium and vecuronium
50. Comparison of cardiovascular effects of pipecuronium versus vecuronium in patients receiving sufentanil anesthesia for myocardial revascularization
51. Proper use of muscle relaxants in non-rapid sequence intubations
52. Intubation difficile. Expertise collective
53. Preoperative airway assessment: Predictive value of a multivariate risk index
54. Awareness, muscle relaxants and balanced anaesthesia
55. Rapid tracheal intubation with vecuronium : The timing principle
56. Rapid tracheal intubation with atracurium: The timing principle
57. Pain on injection of rocuronium bromide
58. The priming principle
59. Rapid tracheal intubation with vecuronium: The priming principle
60. Pharmacodynamics and pharmacokinetics, and intubation conditions after priming with three different doses of vecuronium
61. Priming with rocuronium accelerates the onset of neuromuscular blockade
62. Facilitation of rapid endotracheal intubation with divided doses of non depolarizing neuromuscular blocking drugs
63. Pretreatment with non-depolarizing muscle relaxants: The influence on neuromuscular transmission and pulmonary function
64. Priming doses of atracurium and vecuronium depress swallowing in humans
65. Pulmonary aspiration after a priming dose of vecuronium
66. Effect of priming dose of vecuronium on lung function in elderly patients
67. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium
68. Onset and duration of neuromuscular blockade following high-dose vecuronium administration
69. Clinical pharmacology of atracurium given in high dose
70. Atracurium in clinical anaesthesia : Effect of dosage on onset, duration and conditions for tracheal intubation
71. Rate of onset of good intubationg conditions, respiratory depression and hand muscle paralysis after vecuronium
72. Variability of onset times within and among relaxant regimens
73. Potency of pancuronium at the diaphragm and the adductor pollicis muscles in humans
74. The neuromuscular blocking effect of vecuronium on the human diaphragm
75. Differential effects of pancuronium on masseters and adductor pollicis muscles in humans
76. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi and adductor pollicis muscles
77. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis muscles
78. Rocuronium (Org 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans
79. The orbicularis oculi and the adductor pollicis muscles as monitor of atracurium block of laryngeal muscles
80. A comparison of the neuromuscular blocking effects of atracurium, mivacurium and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans
81. Org 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans
82. Evaluation des conditions d'intubation sous rocuronium
83. Determining the optimal time for endotracheal intubation during onset of neuromuscular blockade
84. Comparison of intubating conditions after rocuronium or vecuronium when the timing of intubation is judged by clinical criteria
85. Timing of tracheal intubation : Monitoring the orbicularis oculi, the adductor pollicis or use a stopwatch ?